SQ109 is a drug undergoing development for treatment of tuberculosis.
SQ109 is a drug undergoing development for treatment of tuberculosis.
==Background== On October 16, 2007, it was given the status of Orphan drug by the U.S. Food and Drug Administration (FDA) for use against drug-susceptible and drug-resistant TB bacteria.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).